Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial

BACKGROUND: Although implantation of cardiac implantable electronic devices (CIEDs) in patients receiving warfarin is well studied, limited data are available on the use of oral factor Xa inhibitors in this setting. METHODS AND RESULTS: Using data from Rivaroxaban Once Daily Oral Direct Factor Xa In...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Am Heart Assoc
Autori principali: Leef, George C., Hellkamp, Anne S., Patel, Manesh R., Becker, Richard C., Berkowitz, Scott D., Breithardt, Günter, Halperin, Jonathan L., Hankey, Graeme J., Hacke, Werner, Nessel, Christopher C., Singer, Daniel E., Fox, Keith A.A., Mahaffey, Kenneth W., Piccini, Jonathan P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669143/
https://ncbi.nlm.nih.gov/pubmed/28615214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.004663
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi